- Home
- BBIO vs JZXN Comparison
BBIO vs JZXN Comparison
Compare BBIO & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- JZXN
- Stock Information
- Founded
- BBIO 2015
- JZXN 2019
- Country
- BBIO United States
- JZXN China
- Employees
- BBIO N/A
- JZXN N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- BBIO Health Care
- JZXN Consumer Discretionary
- Exchange
- BBIO Nasdaq
- JZXN Nasdaq
- Market Cap
- BBIO 6.7B
- JZXN N/A
- IPO Year
- BBIO 2019
- JZXN 2021
- Fundamental
- Price
- BBIO $34.17
- JZXN $2.33
- Analyst Decision
- BBIO Strong Buy
- JZXN
- Analyst Count
- BBIO 12
- JZXN 0
- Target Price
- BBIO $57.09
- JZXN N/A
- AVG Volume (30 Days)
- BBIO 3.1M
- JZXN 330.0K
- Earning Date
- BBIO 04-29-2025
- JZXN 05-19-2025
- Dividend Yield
- BBIO N/A
- JZXN N/A
- EPS Growth
- BBIO N/A
- JZXN N/A
- EPS
- BBIO N/A
- JZXN N/A
- Revenue
- BBIO $127,415,000.00
- JZXN $1,400,139.00
- Revenue This Year
- BBIO $13.67
- JZXN N/A
- Revenue Next Year
- BBIO $118.02
- JZXN N/A
- P/E Ratio
- BBIO N/A
- JZXN N/A
- Revenue Growth
- BBIO N/A
- JZXN N/A
- 52 Week Low
- BBIO $21.62
- JZXN $1.00
- 52 Week High
- BBIO $39.47
- JZXN $7.82
- Technical
- Relative Strength Index (RSI)
- BBIO 44.19
- JZXN 38.81
- Support Level
- BBIO $33.92
- JZXN $2.01
- Resistance Level
- BBIO $39.16
- JZXN $2.30
- Average True Range (ATR)
- BBIO 1.50
- JZXN 0.79
- MACD
- BBIO -0.24
- JZXN -0.19
- Stochastic Oscillator
- BBIO 10.35
- JZXN 12.58
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.